Lebourg, Myriam Madeleine; Martínez Díaz, S.; Garcia Giralt, Natalia; Torres Claramunt, R.; Gómez-Tejedor, José Antonio; Gómez Ribelles, José Luís; Vila Canet, G; Monllau, J.C.(SAGE Publications (UK and US), 2014-05)
Polycaprolactone scaffolds modified with cross-linked hyaluronic acid were prepared in order to establish whether a
more hydrophilic and biomimetic microenvironment benefits the progenitor cells arriving from bone marrow ...
Meseguer Ripollés, José(Universitat Politècnica de València, 2016-05-19)
[EN] Cartilage degeneration is associated to degenerative bone and joint processes within osteoarthritis (OA). At present, OA are difficult to treat, involving very often, a partial or complete join substitution. However, ...
[EN] Osteoarthritis (OA) is the most common joint disorder and a leading cause of disability. Current treatments for OA can improve symptoms but do not delay the progression of disease. In the last years, much effort has ...
[EN] Mesenchymal stem/stromal cells (MSCs) represent a promising therapy for musculoskeletal diseases. There is compelling evidence indicating that MSC effects are mainly mediated by paracrine mechanisms and in particular ...
[EN] Extracellular vesicles (EVs) are attracting increasing interest since they might represent a more convenient therapeutic tool with respect to their cells of origin. In the last years much time and effort have been ...
[EN] Background/Aims: Chronic inflammation contributes to cartilage degeneration during the progression of osteoarthritis (OA). Adipose tissue-derived mesenchymal stem cells (ADMSC) show great potential to treat inflammatory ...
[EN] Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a master regulator of cellular protective processes. Rheumatic diseases are chronic conditions characterized by inflammation, pain, tissue damage and limitations ...